Please use this identifier to cite or link to this item:
The Chemo Collaborate: Improving the Process of Chemotherapy Administration in the Inpatient Setting
|2016-05-dnp-blasiak r.pdf||Version for non-UH users. Copying/Printing is not permitted||2.9 MB||Adobe PDF||View/Open|
|2016-05-dnp-blasiak uh.pdf||For UH users only||3.11 MB||Adobe PDF||View/Open|
|Title:||The Chemo Collaborate: Improving the Process of Chemotherapy Administration in the Inpatient Setting|
|Date Issued:||May 2016|
|Publisher:||[Honolulu] : [University of Hawaii at Manoa], [May 2016]|
The lack of a standardized chemotherapy and biotherapy administration process in the inpatient setting of Pali Momi Medical Center (PMMC) led to variations in practice and resulting patient safety concerns. The Iowa Model of Evidenced-Based Practice to Improve Quality Care framework was the conceptual framework for this evidenced-based practice project. The purpose was to improve the inpatient intravenous chemotherapy and biotherapy administration process to impact patient care by increasing positive patient outcomes post-chemotherapy.
A quality improvement design was used to implement this project. The innovation of this project included a new policy and procedure, multiple methods of training and education, and the implementation of a detailed communication process prior to chemotherapy administration. Data collection was primarily grounded in chart reviews of all patients who received intravenous chemotherapy and or biotherapy at PMMC. The results of intensive staff education and training was collected from documentation of competencies from the electronic staff training record. Staff surveys were completed to evaluate staff perceptions of project impact.
The new chemotherapy and biotherapy policy was successfully adopted at PMMC and included details of the administration process, safety standards, and minimal requirements to be considered a chemotherapy competent nurse. A total of 12 nurses had training and chemotherapy education during the intervention period.
Adoption of the policy and the new communication process was measured by nurse, physician, and pharmacist compliance related to chemotherapy ordering, review and release; at last measure, compliance rates for each role was 100%, 100%, and 75%, respectively. Additionally, patient initial and ongoing education occurred 100% of the time in the last 10 months of the project. A multidisciplinary survey revealed that all responders (n=16) found an improvement in the chemotherapy and biotherapy administration process at PMMC, noted staff satisfaction, and a perceived increase in safety measures.
The Chemotherapy Collaborate resulted in safer and higher quality care for patients receiving chemotherapy and biotherapy in the inpatient setting at PMMC and successfully impacted the development of nursing staff. Furthermore, staff identified a perceived improvement in safety, efficiency, quality, and process of intravenous chemotherapy administration.
|Description:||D.N.P. University of Hawaii at Manoa 2016.|
Includes bibliographical references.
|Appears in Collections:||
D.N.P. - Nursing Practice|
Please email firstname.lastname@example.org if you need this content in ADA-compliant format.
Items in ScholarSpace are protected by copyright, with all rights reserved, unless otherwise indicated.